DPRX activators consist of chemical agents tailored to modulate the activity of the DPRX protein, a member of a broader family of proteins that may play a role in cellular processes. The DPRX acronym typically stands for a specific protein or gene product, which in the context of such activators, suggests a focus on a protein whose functional dynamics are of interest within the field of molecular biology. Proteins similar to DPRX are often involved in the regulation of gene expression, cellular differentiation, or interaction with other cellular proteins. Activators of this class are designed to engage with the DPRX protein in a way that enhances its natural activity, which could involve increasing its binding affinity to other proteins or nucleic acids, altering its conformational state to a more active form, or stabilizing the protein against degradation. The development of DPRX activators demands a sophisticated understanding of the protein's structure, the key domains or motifs that are critical for its function, and the biological pathways in which the protein is implicated.
The identification of DPRX activators commences with extensive research into the protein's role and mechanism of action within the cell. High-throughput screening methods may be employed to sift through vast compound libraries to find molecules that can elevate the activity of DPRX. These initial hits are then typically subjected to further validation and characterization assays to confirm their specificity and elucidate their mode of action. This validation is crucial because it ensures that the activators are not producing unintended effects on other proteins or cellular components. Following the confirmation of activity, the chemical structure of these activators is refined through an iterative process that involves synthetic chemistry, computational modeling, and structure-activity relationship (SAR) studies. The interplay between these approaches facilitates the enhancement of the activator's properties, such as its binding efficiency and specificity for DPRX. Structural biology techniques, including X-ray crystallography and cryo-electron microscopy, may be utilized to visualize the interaction at an atomic level, providing insights that drive further chemical modifications. The ultimate goal of this meticulous optimization process is to produce highly selective and potent DPRX activators, which could serve as instrumental tools in probing the protein's function and its contribution to the complex network of cellular signaling pathways.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
It may demethylate DNA, potentially leading to the activation of gene expression, which could include genes like DPRX. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
As an isoflavone, it may act as an epigenetic modulator, potentially influencing the expression of various genes including DPRX. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
It is known to modulate several signaling pathways, which might indirectly upregulate the expression of certain genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A polyphenol that could affect gene expression through epigenetic mechanisms, potentially impacting DPRX expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-azacytidine, it may induce gene expression by DNA demethylation, possibly affecting DPRX. | ||||||
Vinclozolin | 50471-44-8 | sc-251425 | 250 mg | $23.00 | 1 | |
An antiandrogenic compound that could disrupt normal hormone signaling, potentially leading to altered gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A glucocorticoid that can regulate genes through the glucocorticoid receptor, potentially affecting DPRX expression. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that might have a broad range of effects on gene expression through epigenetic alterations. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $70.00 $281.00 $536.00 $1076.00 $2142.00 | 3 | |
A synthetic estrogen that could modulate gene expression via estrogen receptor signaling, potentially impacting DPRX. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
As a histone deacetylase inhibitor, it may increase gene expression by affecting chromatin structure and accessibility of genes. |